Loading company…
Zedira develops recombinant microbial transglutaminase for antibody-drug conjugate applications.
Zedira develops Andracon™, a recombinant microbial transglutaminase used in site-specific antibody-drug conjugate production. It serves pharmaceutical companies and research organizations developing targeted therapies. Founded in 2007 and based in Darmstadt, Germany, it received growth financing from High-Tech Grunderfonds in May 2010.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in